Expanding the Clinical and Immunological Phenotypes and Natural History of MALT1 Deficiency

2022-01-01
Sefer, Asena Pinar
Abolhassani, Hassan
Ober, Franziska
Kayaoğlu, Başak
Eltan, Sevgi Bilgic
Kara, Altan
ERMAN, BARAN
Yilmaz, Naz Surucu
Aydogmus, Cigdem
Aydemir, Sezin
Charbonnier, Louis-Marie
KOLUKISA, BURCU
Azizi, Gholamreza
Delavari, Samaneh
Momen, Tooba
Aliyeva, Simuzar
Demirkol, Yasemin Kendir
Tekin, Saban
KIYKIM, AYÇA
Baser, Omer Faruk
ÇOKUĞRAŞ, HALUK CEZMİ
Gürsel, Mayda
Karakoc-Aydiner, Elif
Ozen, Ahmet
Krappmann, Daniel
Chatila, Talal A.
Rezaei, Nima
BARIŞ, SAFA
Purpose MALT1 deficiency is a combined immune deficiency characterized by recurrent infections, eczema, chronic diarrhea, and failure to thrive. Clinical and immunological characterizations of the disease have not been previously reported in large cohorts. We sought to determine the clinical, immunological, genetic features, and the natural history of MALT-1 deficiency. Methods The clinical findings and treatment outcomes were evaluated in nine new MALT1-deficient patients. Peripheral lymphocyte subset analyses, cytokine secretion, and proliferation assays were performed. We also analyzed ten previously reported patients to comprehensively evaluate genotype/phenotype correlation. Results The mean age of patients and disease onset were 33 +/- 17 and 1.6 +/- 0.7 months, respectively. The main clinical findings of the disease were recurrent infections (100%), skin involvement (100%), failure to thrive (100%), oral lesions (67%), chronic diarrhea (56%), and autoimmunity (44%). Eosinophilia and high IgE were observed in six (67%) and two (22%) patients, respectively. The majority of patients had normal T and NK cells, while eight (89%) exhibited reduced B cells. Immunoglobulin replacement and antibiotics prophylaxis were mostly ineffective in reducing the frequency of infections and other complications. One patient received hematopoietic stem cell transplantation (HSCT) and five patients died as a complication of life-threatening infections. Analyzing this cohort with reported patients revealed overall survival in 58% (11/19), which was higher in patients who underwent HSCT (P = 0.03). Conclusion This cohort provides the largest analysis for clinical and immunological features of MALT1 deficiency. HSCT should be offered as a curative therapeutic option for all patients at the early stage of life.
JOURNAL OF CLINICAL IMMUNOLOGY

Suggestions

Evaluation of disseminated candidiasis on an experimental animal model: A Fourier transform infrared study
Dogan, Ayca; Ergen, Kivanc; Budak, Fatma; Severcan, Feride (SAGE Publications, 2007-02-01)
Invasive candidiasis, defined as candidemia and disseminated candidiasis, is the most common fungal infection in hospitalized patients. In the current study, we used Fourier transform infrared (FT-IR) spectroscopy as a rapid, non-perturbing technique to investigate the effects of disseminated candidiasis on mouse liver tissues at the molecular level. The results revealed that the infection caused compositional changes in the tissues by decreasing the lipid content and the ratio of the saturated lipids to un...
Development of an experimental recombinant vaccine formulation composed of LKTA from Mannheimia Haemolytica A1 and P31 and LPPB from Histophilus Somni 8025 against Hovine Respiratory Disease
Türkmen, Nazlı Hilal; Özcengiz, Gülay; Department of Molecular Biology and Genetics (2020-9)
Two major bacterial pathogens of Bovine Respiratory Disease (BRD), Mannheimia haemolytica and Histophilus somni are Gram-negative, opportunistic bacteria that live in upper respiratory tracts of ruminants commensally. The one of the most important virulence factor of M. haemolytica, leukotoxin, is responsible for lung colonization and establishment of infection. On the other hand, H. somni OMPs have a significant contribution to the pathogenicity of the organism. As the disease results in a destroyed animal...
Characterization of leishmania RNA virus infected leishmania major exosomes and evaluation of the impact of cytosolic DNA sensing related pathways in L. Major infection
Yılmaz, İsmail Cem; Gürsel, Mayda; Department of Biology (2020)
Leishmaniasis is a neglected infectious disease caused by Leishmaniaparasite. The disease represents a significant health problem, necessitating urgent development of effective treatment strategies. New World Leishmaniaspecies harboringLeishmania RNA virus (LRV) causesevere,metastatic disease. In this thesis, we compared LRV2-1 deficient and proficient Old World L. majorstrains in terms of their exosomal content and infectivity. PCR and mass spectrometry based analysis revealed that virus infectedLeishm...
Recent developments in cell-based assays and stem cell technologies for botulinum neurotoxin research and drug discovery.
Kiriş, Erkan; Burnett, JC; Soloveva, V; Kane, CD; Bavari, S (2014-03-01)
Botulinum neurotoxins (BoNTs) are exceptionally potent inhibitors of neurotransmission, causing muscle paralysis and respiratory failure associated with the disease botulism. Currently, no drugs are available to counter intracellular BoNT poisoning. To develop effective medical treatments, cell-based assays provide a valuable system to identify novel inhibitors in a time- and costefficient manner. Consequently, cell-based systems including immortalized cells, primary neurons, and stem-cell derived neurons h...
Analysis of the effects of vancomycin containing bioceramic/polymer composites on biofilm prevention, biocompatibility and osteogenic modification of mesenchymal stem cells
Kankılıç, Berna; Bayramlı, Erdal; Korkusuz, Feza; Department of Biotechnology (2015)
Osteomyelitis is a difficult to treat bone infection. In clinic, osteomyelitis is treated with surgical debridement followed by the antibiotic therapy. But, due to the low blood circulation in the infection area and the production of an exopolysaccharide, biofilm, by the pathogen violence the treatment. Therefore local drug delivery systems are generated. These systems transmit the effective dose to the infection area without any toxic effects. In this study, vancomycin containing PDLLA/β-TCP and PLGA/β-TCP...
Citation Formats
A. P. Sefer et al., “Expanding the Clinical and Immunological Phenotypes and Natural History of MALT1 Deficiency,” JOURNAL OF CLINICAL IMMUNOLOGY, pp. 0–0, 2022, Accessed: 00, 2022. [Online]. Available: https://hdl.handle.net/11511/95416.